Cargando…
One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis
BACKGROUND: In Germany, the first case of coronavirus disease 2019 (COVID-19) was registered on 28 January 2020. By February 2021, the third wave of the pandemic began. So far, only few data are available on the SARS-CoV-2 prevalence and the clinical impact of an infection in patients with cystic fi...
Autores principales: | Jaudszus, Anke, Pavlova, Mariya, Rasche, Marius, Baier, Michael, Moeser, Anne, Lorenz, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943512/ https://www.ncbi.nlm.nih.gov/pubmed/35331203 http://dx.doi.org/10.1186/s12890-022-01900-8 |
Ejemplares similares
-
Pseudomonas aeruginosa colonization in the upper and lower airways of a child with cystic fibrosis: a father’s meticulous approach to successful eradication
por: Mainz, Jochen Georg, et al.
Publicado: (2019) -
Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis Patients
por: Tabori, Harold, et al.
Publicado: (2017) -
Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings
por: Tabori, Harold, et al.
Publicado: (2017) -
One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway
por: Jean-Pierre, Fabrice, et al.
Publicado: (2021) -
Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients
por: Wetzstein, Nils, et al.
Publicado: (2022)